Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P160026/S069

LIFEPAK 35 monitor/defibrillator

Physio-Control, Inc. · Decision date Sep 2, 2026

MEDTECHLEDGER EXPLANATIONP160026/S069

What did the FDA approve?

FDA approved supplement S069 to PMA P160026 for the LIFEPAK 35 monitor/defibrillator on September 2, 2026. The supplement describes a minor design change to the EtCO2 module of the LIFEPAK35. The applicant is Physio-Control, Inc., and the supplement type is Real-Time Process, with the stated reason being a change to design, components, specifications, or material.

This supplement is not a new approval of the entire system; it addresses only the EtCO2 module change under the existing PMA. The device category is automated external defibrillators (non-wearable), product code MKJ, specialty cardiovascular. The source statement does not specify the exact nature of the design change, any testing performed, or any clinical or safety outcomes. The reported purpose is distinct from independent proof of safety or clinical effectiveness.

FDA approval order statement

a minor design change to the EtCO2 module of the LIFEPAK35
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Cardiovascular
Decision date
Sep 2, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P160026/S069
Regulatory pathway
PMA supplement
Product code
MKJ
Decision code
APPR
Decision date
Sep 2, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automated external defibrillators (non-wearable).

Product code
MKJ
FDA device class
3

For the original device and its historical approval scope, see PMA P160026. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P160026 · Original PMA

    LIFEPAK 1000 DEFIBRILLATOR, LIFEPAK 20 DEFIBRILLATOR/ MONITOR, LIFEPAK 20E DEFIBRILLATOR/ MONITOR, LIFEPAK 15 MONITOR/DE

  2. P160026/S069 received

    Application receipt date recorded by FDA.

  3. P160026/S069 · FDA decision

    Real-Time Process

  4. P160026/S073 · Related supplement

    LIFEPAK 15 monitor/defibrillator

  5. P160026/S074 · Related supplement

    LIFEPAK 1000 DEFIBRILLATOR, LIFEPAK 20 DEFIBRILLATOR/ MONITOR, LIFEPAK 20E DEFIBRILLATOR/ MONITOR, LIFEPAK 15 MONITOR/DE

  6. P160026/S076 · Related supplement

    LIFEPAK 35 monitor/defibrillator

Timeline entries are records held by MedtechLedger for P160026. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P160026

Explore the linked device profile

Other records with product code MKJ

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Physio-Control, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
11811 Willows Rd. NE, Redmond, WA, 98052

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records